Until his recent death, Dr. Korsmeyer was also Sidney Farber Professor of Pathology and Medicine at Harvard Medical School and Director of the Program in Molecular Oncology at the Dana-Farber Cancer Institute. He received his B.S. degree in biology from the University of Illinois, Urbana, and his M.D. degree from the University of Illinois, Chicago. He did his internship and residency in medicine at the University of California, San Francisco. His postdoctoral research was done with Thomas Waldmann and Philip Leder at the National Cancer Institute, where he became a senior investigator. Prior to his move to Harvard and the Dana-Farber Institute, Dr. Korsmeyer was an HHMI investigator and Chief of the Division of Molecular Oncology at Washington University School of Medicine. He was a member of the National Academy of Sciences and the Institute of Medicine, and was recently elected to the American Philosophical Society. His honors include the Bristol-Myers Squibb Award for distinguished achievement in cancer research, the Charles S. Mott Prize of the General Motors Cancer Research Foundation, the 2000 Louisa Gross Horwitz Prize, the first annual Wiley Prize in the Biomedical Sciences, the Leukemia & Lymphoma Society's de Villiers International Achievement Award, and the International Award for Cancer Research from the Pezcoller Foundation and the American Association for Cancer Research.
RESEARCH ABSTRACT SUMMARY:
Stan Korsmeyer did pioneering work on the regulation of apoptosis. He identified the key genetic mechanisms that govern cell death and survival and defined the role of cell death in the pathogenesis of human diseases, including lymphomas and other cancers.
View Research Abstract
Photo: Steve Gilbert